| Product Name | Catalog Number | CAS | MSDS |
|---|---|---|---|
| Avanafil Metabolite (M-4) II | NVIP01564 | MSDS | |
| Avanafil Metabolite (M-16) | NVIP01565 | MSDS | |
| Avanafil-13CD3 | NVIP01566 | MSDS | |
| methyl 6,6-dimethyl-3-(1R,2S,5S)-azabicyclo[3.1.0]hexane-2-carboxylate | NV672325234 | 672325-23-4 | MSDS |
| (S)-2-(3-(tert-butyl)ureido)-3,3-dimethylbutanoic acid | NV101968858 | 101968-85-8 | MSDS |
| (1R,2S,5S)-3-((S)-2-(3-tert-butylureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | NV816444903 | 816444-90-3 | MSDS |
| 3-Amino-4-cyclobutyl-2-oxobutanamide | NV816444958 | 816444-95-8 | MSDS |
| (3R,7aS)-3-phenyl-tetrahydro-pyrrolo[1,2-c]oxazol-5-one | NV103201792 | 103201-79-2 | MSDS |
| (3R,7aS)-3-phenyl-3,7a-dihydro-1H-pyrrolo[1,2-c]oxazol-5-one | NV134107656 | 134107-65-6 | MSDS |
| tert-butyl (1R,2S,5S)-2-(hydroxymethyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate | NV219754004 | 219754-00-4 | MSDS |
